Arteris director’s trust sells 109,721 AIP shares

Arteris, Inc. director Saiyed Atiq Raza reported open‑market sales of 109,721 shares of common stock by the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust.

Rhea-AI Filing Summary

Arteris, Inc. director Saiyed Atiq Raza reported open‑market sales of 109,721 shares of common stock by the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust. The trust sold 106,031 shares on March 2, 2026 at a weighted average price of $17.2127 and 3,690 shares on March 4, 2026 at a weighted average price of $17.0153, under a pre‑arranged Rule 10b5‑1 trading plan.

After these transactions, the trust held 390,000 shares indirectly, and Raza also held 20,839 shares directly.

Insider Trade Summary

Net Seller: 109,721 shares

Net Sell 3 txns

Insider RAZA SAIYED ATIQ

Role Director

Sold 109,721 shs ($1.89M)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,690	$17.0153	$63K
Sale	Common Stock	106,031	$17.2127	$1.83M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 390,000 shares (Indirect, Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012); Common Stock — 20,839 shares (Direct)

Footnotes (4)

1. F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025.
2. F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.
4. F4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.07 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Arteris (AIP) disclose in this Form 4?

Arteris disclosed that a trust associated with director Saiyed Atiq Raza sold 109,721 shares of common stock in open‑market transactions. These trades occurred on March 2 and March 4, 2026, at weighted average prices slightly above $17 per share.

Who executed the Arteris (AIP) share sales reported for Saiyed Atiq Raza?

The sales were executed by the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which Raza serves as trustee. The Form 4 shows these holdings as indirect ownership, distinguishing them from his smaller directly held share position.

How many Arteris (AIP) shares did the trust sell and at what prices?

The trust sold 106,031 Arteris shares on March 2, 2026 at a weighted average price of $17.2127, and 3,690 shares on March 4, 2026 at a weighted average price of $17.0153. Both trades are reported as open‑market sales of common stock.

Were the Arteris (AIP) insider sales made under a 10b5‑1 trading plan?

Yes. A footnote explains that the transactions were made under a Rule 10b5‑1 trading plan adopted on November 7, 2025. Such plans pre‑schedule trades, helping insiders diversify holdings while limiting concerns about trading on nonpublic information.

How many Arteris (AIP) shares does Saiyed Atiq Raza own after these trades?

After the reported sales, the revocable trust held 390,000 Arteris shares as indirect ownership. Separately, the Form 4 shows Raza directly owning 20,839 shares of common stock, reflecting his remaining personal position outside the trust structure.

What types of transactions are shown in this Arteris (AIP) Form 4?

The Form 4 shows two open‑market sales of common stock, both coded as transaction type “S,” and one line reflecting direct holdings. The sales reduced the trust’s position, while a separate entry lists Raza’s directly held 20,839‑share balance after the activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 06:10 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RAZA SAIYED ATIQ

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		S(1)		106,031	D	$17.2127(2)	393,690	I	Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012(3)
Common Stock	03/04/2026		S(1)		3,690	D	$17.0153(4)	390,000	I	Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012(3)
Common Stock								20,839	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.

4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.07 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for S. Atiq Raza	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.